glp-1 and thc Analogues in the Neurobiology of Addiction: Translational Insights Therapeutic Perspectives New Study Links GLP-1 Medications

Your body will need time to adjust to this new dose

Published online July 19, 2023

This manuscript was prepared according to the International Society for Medical Publication Professionals Good Publication Practice for Communicating Company-Sponsored Medical Research: the GPP3 Guidelines

Individuals using GLP-1 treatments, such as those in programs like Tyde Wellness, report an average body weight reduction of 15% after 68 weeks, with many achieving weight loss of over 20-25% within a year

All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Complete tablet erosion occurred in the stomach